KRAS, BRAF, and PIK3CA mutations, and patient prognosis in 126 pancreatic cancers: pyrosequencing technology and literature review. (Q38755270)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26927447%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

title

KRAS, BRAF, and PIK3CA mutations, and patient prognosis in 126 pancreatic cancers: pyrosequencing technology and literature review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26927447%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26927447%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Hideo Baba

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26927447%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

author name string

Lei Zhou

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26927447%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Yoshifumi Baba

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26927447%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Yuki Kitano

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26927447%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Keisuke Miyake

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26927447%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Xiaobo Zhang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26927447%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Kensuke Yamamura

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26927447%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Keisuke Kosumi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26927447%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Takayoshi Kaida

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26927447%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Kota Arima

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26927447%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Katsunobu Taki

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26927447%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Takaaki Higashi

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26927447%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Katsunori Imai

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26927447%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Daisuke Hashimoto

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26927447%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Yoichi Yamashita

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26927447%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Akira Chikamoto

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26927447%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Toru Beppu

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26927447%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

publication date

29 February 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26927447%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26927447%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26927447%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26927447%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

page(s)

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26927447%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s12032-016-0745-9

9 March 2020

exact match

0 references

cites work

Association of poor prognosis with loss of 12q, 17p, and 18q, and concordant loss of 6q/17p and 12q/18q in human pancreatic ductal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS12032-016-0745-9

Global cancer statistics, 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-016-0745-9

Validation of the 6th edition AJCC Pancreatic Cancer Staging System: report from the National Cancer Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-016-0745-9

Role of RAF/MEK/ERK pathway, p-STAT-3 and Mcl-1 in sorafenib activity in human pancreatic cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-016-0745-9

Roles of EGFR and KRAS and their downstream signaling pathways in pancreatic cancer and pancreatic cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-016-0745-9

Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-016-0745-9

The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-016-0745-9

AKT/PKB signaling: navigating downstream

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-016-0745-9

Pyrosequencing: an accurate detection platform for single nucleotide polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-016-0745-9

Sensitive sequencing method for KRAS mutation detection by Pyrosequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-016-0745-9

Pyrosequencing data analysis software: a useful tool for EGFR, KRAS, and BRAF mutation analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-016-0745-9

Comparison of GenFlex Tag Array and Pyrosequencing in SNP Genotyping

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-016-0745-9

Specific mutations in KRAS codons 12 and 13, and patient prognosis in 1075 BRAF wild-type colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-016-0745-9

KRAS mutation in stage III colon cancer and clinical outcome following intergroup trial CALGB 89803

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-016-0745-9

Are RAS mutations predictive markers of resistance to standard chemotherapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-016-0745-9

Blocking oncogenic Ras signaling for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-016-0745-9

COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-016-0745-9

Impact of epidermal growth factor receptor (EGFR) kinase mutations, EGFR gene amplifications, and KRAS mutations on survival of pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-016-0745-9

KRAS mutations in codon 12 or 13 are associated with worse prognosis in pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-016-0745-9

KRAS mutant allele-specific imbalance is associated with worse prognosis in pancreatic cancer and progression to undifferentiated carcinoma of the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-016-0745-9

Prognostic value of K-ras mutation status and subtypes in endoscopic ultrasound-guided fine-needle aspiration specimens from patients with unresectable pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-016-0745-9

Targeting phosphoinositide 3-kinase pathways in pancreatic cancer--from molecular signalling to clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-016-0745-9

Mutations of the BRAF gene in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-016-0745-9

BRAF mutation is associated with early stage disease and improved outcome in patients with low-grade serous ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-016-0745-9

Prognostic value of BRAF(V⁶⁰⁰) mutations in melanoma patients after resection of metastatic lymph nodes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-016-0745-9

Reporting tumor molecular heterogeneity in histopathological diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-016-0745-9

Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-016-0745-9

PIK3CA mutations frequently coexist with RAS and BRAF mutations in patients with advanced cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-016-0745-9

Coordinated epidermal growth factor receptor pathway gene overexpression predicts epidermal growth factor receptor inhibitor sensitivity in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-016-0745-9

Resequencing analysis of the human tyrosine kinase gene family in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-016-0745-9

Molecular analysis of the EGFR-RAS-RAF pathway in pancreatic ductal adenocarcinomas: lack of mutations in the BRAF and EGFR genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-016-0745-9

BRAF and K-ras gene mutations in human pancreatic cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-016-0745-9

EGFR and KRAS Mutational Analysis and Their Correlation to Survival in Pancreatic and Periampullary Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-016-0745-9

Oncogenic mutations of PIK3CA in human cancers

21 January 2018

1 reference

12 December 2020

Akt as a therapeutic target in cancer

1 reference

12 December 2020

K-ras oncogene subtype mutations are associated with survival but not expression of p53, p16(INK4A), p21(WAF-1), cyclin D1, erbB-2 and erbB-3 in resected pancreatic ductal adenocarcinoma

1 reference

12 December 2020

Pancreatic adenocarcinoma

1 reference

12 December 2020

Progression model for pancreatic cancer.

1 reference

12 December 2020

Clinicopathological characteristics and prognostic impact of colorectal cancers with NRAS mutations

1 reference

12 December 2020

7th Edition of the AJCC Cancer Staging Manual: Esophagus and Esophagogastric Junction

1 reference

12 December 2020

Frequencies and prognostic role of KRAS and BRAF mutations in patients with localized pancreatic and ampullary adenocarcinomas.

1 reference

12 December 2020

10.1007/S12032-016-0745-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26927447%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

9 March 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26927447%20AND%20SRC:MED&resulttype=core&format=json